Crossmark

Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance

Crossref DOI link: https://doi.org/10.1016/j.immuni.2019.07.003

Published Print: 2019-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rivadeneira, Dayana B.

DePeaux, Kristin

Wang, Yiyang

Kulkarni, Aditi

Tabib, Tracy

Menk, Ashley V.

Sampath, Padmavathi

Lafyatis, Robert

Ferris, Robert L.

Sarkar, Saumendra N.

Thorne, Stephen H.

Delgoffe, Greg M.
Funding

Funding for this research was provided by:

National Institutes of Health

Alliance for Cancer Gene Therapy

Stand Up To Cancer
License Information

Text and Data Mining valid from 2019-09-01

Text and Data Mining valid from 2019-09-01

Version of Record valid from 2020-09-18
More Information

This article is maintained by: Elsevier

Article Title: Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance

Journal Title: Immunity

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.immuni.2019.07.003

Content Type: article

Copyright: © 2019 Elsevier Inc.